AKYLA/ Financials
MarketsScreenerFinancialsResearchChat
Equity / SERVICES-NURSING & PERSONAL CARE FACILITIES
Regentis Biomaterials Ltd.
XASE · usd
SIC 8050 · SERVICES-NURSING & PERSONAL CARE FACILITIES
FIGI AK-6870D9674C
1.28▼ 0.12 (-8.57%)
As of 2026-10-23
Price / Volume
Valuation
Market Cap
Enterprise Value
—
Trailing P/E
—
Price / Sales
—
EV / Revenue
—
EV / EBITDA
—
Financial Highlights
Revenue (TTM)
—
Net Income (TTM)
—
EBITDA
—
Diluted EPS (TTM)
—
EBITDA Margin
—
Net Debt
—
Trading Information
Previous Close
1.40
Day's Range
1.28 – 1.42
52-Week Range
1.23 – 15.50
Volume
18.2K
Avg Volume
55.4K
Share Statistics
Shares Outstanding
Employees
8
Exchange
XASE
Listed
2025-12-04
Share count as of June 30, 2026

Regentis Biomaterials Ltd. (RGNT) Financial Statements

View
Income Statement
Detail
Standard
Period
Quarterly
Loading Income Statement…
Key questions about Regentis Biomaterials Ltd. (RGNT)
What is Regentis Biomaterials Ltd.'s Market Cap?
Regentis Biomaterials Ltd.'s Market Cap is $9.0M, based on as-reported figures from SEC (XBRL) filings.
Akyla / Financials · RGNTAs-filed SEC (XBRL) data
No Quarterly data available for this company — showing Annual instead. This company files annual reports only — foreign private issuers (Form 20-F / 40-F) are not required to file quarterly reports, so no quarterly figures exist to show.
Showing the most recent year. Subscribe for full statement history.
Income Statement(in thousands, except per-share data)
Source: Akyla.ai
Line ItemDec 31, 2025Dec 31, 2024Dec 31, 2023
Operating expenses:
Research and development expenses:
General and administrative expenses
Operating loss
Financial income (expenses), net:
Change in fair value of convertible notes
Change in fair value of warrant liability
Other financing expenses, net
Net loss
Basic net loss per share
Diluted net loss per share